Intravenous Dexmedetomidine on Inflammatory Mediators in Patients candidate of Surgery
Phase 3
Recruiting
- Conditions
- Abdominal Hysterectomy.
- Registration Number
- IRCT20180506039558N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Female candidate of Total Abdominal Hysterectomy (TAH)
Body mass index (BMI): 18 to 40 kg/m2
American Society of Anesthesiologists (ASA) classification I , II
Exclusion Criteria
Allergic reaction to Dexmedetomidine
History of Dexmedetomidine administration over the past week
History of heart, lung, liver, and kidney diseases
Patients with neurological or neuromuscular disorders
Patients with anemia or bleeding disorders
Consumption of Alcohol, narcotic and Antipsychotic medications
Patients with diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method